The FOrMe Registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorProf. Dr. Paul Brinkkoetter
About this trial
In a monocentric, later multicentric prospective approach the FOrMe registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry) aims to generate a longitudinal cohort of 150 pediatric cases of idiopathic nephrotic syndrome and 350 adult cases of biopsy-proven Minimal Change Disease (MCD) or Focal and Segmental Glomerular Sclerosis (FSGS) over 10 years. The registry will provide a repository for biomaterials such as blood samples, DNA, urine, feces, and tissue biopsies that will be accessible to collaborators to facilitate future research on pathogenesis, diagnostics, and treatment.
Eligibility criteria
Qualifiers
written informed consent
17 or less years of age
idiopathic nephrotic syndrome
written informed consent
Disqualifiers
Prior kidney transplant without biopsy-proven recurrence
A clinical diagnosis of other glomerular disease resulting in secondary MCD or FSGS as judged by the treating physicians.
Refusal to provide written informed consent
(Anticipated) incompliance with visit schedule
Trial design
Treatments tested in this trial
- Biosampling
Treatment groups
500 Participants
are divided into 2 treatment groupsSponsors and collaborators
Prof. Dr. Paul Brinkkoetter
Lead sponsor
University of Cologne
Sponsor institution
German Research Foundation
Collaborator
Medical Faculty and the Faculty of Natural Sciences of the University of Cologne
Collaborator
Cluster of Excellence on Cellular Stress Responses in Ageing-Associated Diseases
Collaborator
Cologne Center for Genomics
Collaborator
Source ClinicalTrials.gov